Back to Search Start Over

Whole-mount prostate sections reveal differential endoglin expression in stromal, epithelial, and endothelial cells with the development of prostate cancer.

Authors :
Kassouf, W.
Ismail, H. R. A.
Aprikian, A. G.
Chevalier, S.
Source :
Prostate Cancer & Prostatic Diseases; 2004, Vol. 7 Issue 2, p105-110, 6p, 1 Color Photograph, 5 Charts
Publication Year :
2004

Abstract

Endoglin is a nonsignaling receptor for transforming growth factor that contributes to the action of this growth factor in diverse cell types. It may also exhibit a function of its own. Endoglin levels vary with disease states and is a marker of new blood vessels. We studied endoglin expression in whole-mount prostate sections from 64 patients with localized prostate cancer, assessing reactivity in the epithelium, the stroma, and blood vessels. Cells in normal/benign acini were negative but significantly immunoreactive (P<0.001) in both prostatic intraepithelial neoplasia (PIN; 52% of cases) and malignant areas (77% of cases). In tumors, this involved less than 25% of malignant cells in 59% of specimens. The endoglin-stained stroma was detected mainly in areas surrounding PIN acini and tumors. Endoglin antibodies detected more microvessels than von Willebrand Factor antibodies in all prostatic areas (P<0.01). In addition, the number of microvessels increased with the development of cancer and correlated with Gleason score (P<0.01). Changes in endoglin expression in PIN and malignant cells, the surrounding stroma, and related blood vessels, suggest that endoglin function may be altered in prostate cancer.Prostate Cancer and Prostatic Diseases (2004) 7, 105-110. doi:10.1038/sj.pcan.4500716 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13657852
Volume :
7
Issue :
2
Database :
Complementary Index
Journal :
Prostate Cancer & Prostatic Diseases
Publication Type :
Academic Journal
Accession number :
13296973
Full Text :
https://doi.org/10.1038/sj.pcan.4500716